News & Trends - Pharmaceuticals
PBS process improvements impacted by COVID-19

Pharma News: On 12 February 2020, the Department of Health hosted a webinar to commence broad consultation on proposed fee changes for Pharmaceutical Benefits Scheme (PBS) and National Immunisation Plan (NIP) listings.
This was followed by a public consultation period from 17 February to 16 March 2020.
As outlined at the webinar and in the consultation document, Stage 2 PBS process improvements and supporting cost recovery arrangements were to be implemented from 1 July 2020, pending Government agreement.
Overview of Stage 2 PBS Process Improvements
- Changes to initial submission categories (including introduction of a single submission date)
- Introduction of resubmission pathways for submissions not recommended by the PBAC
- Revised cost recovery arrangements to support implementation of Stage 2 process improvements.
- Other improvements, including IT system changes
You may also like PRIME Awards 2020 call for entries – the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries.
The current COVID-19 pandemic may impact the government approval of Stage 2 PBS process improvements and supporting cost recovery arrangements and a 1 July 2020 implementation date is now unlikely.
As a result, applicants should be prepared for the current processes and the 2020-21 fees indicated in the 2019-20 Cost Recovery Implementation Statement (CRIS) and the Regulations, pending government approval of some minor amendments, to commence from 1 July 2020. These proposed 2020-21 fees were included in consultations last year.
A 2020-21 CRIS, which will outline the fees to apply from 1 July 2020 will be released as soon as possible.
Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
Human Resources

Decoding Novartis’ blueprint for AI-powered workforce and a reimagined workplace: International HR Day
As International HR Day (20 May) spotlights the theme HumanifyAI – Leading Change in a Dynamic World, Saada McNamee, Country […]
MoreMedical and Science

What powers GenesisCare’s bold path in cancer research: Clinical Trials Day
What does it take to deliver research that truly changes lives? For Sonya McColl, National Research Manager of Oncology at […]
MoreNews & Trends - MedTech & Diagnostics

Are we chasing value-based healthcare while ignoring the elephant in the hospital corridors?
The health system is stuck in a volume-driven framework that rewards throughput over quality. It’s a model that no longer […]
MoreNews & Trends - MedTech & Diagnostics

Former APHA CEO joins day hospitals group amid strategic growth phase
Cura Day Hospitals Group has announced the appointment of Michael Roff, former CEO of the Australian Private Hospitals Association (APHA), […]
More